Recombinant Protein of Human RPL13, aa 1-211(Cat#: RIJL-0225-JL252)
This product is a recombinant human RPL13 protein with N-terminal His Tag. It is availible for SDS-PAGE, WB, ELISA, bioactivity testing and immunogen.
Summary
Related Products & Services
Description
|
This product is a recombinant human RPL13 protein with N-terminal His Tag. It is availible for SDS-PAGE, WB, ELISA, bioactivity testing and immunogen. |
Product Property
Species Reactivity |
Human |
Molecule Mass |
18.8 kDa |
Purity |
>85% determined by SDS-PAGE |
Endotoxin |
<1.0EU per 1µg (determined by the LAL method) |
Expression Host |
E.coli |
Formulation |
Tris/PBS-based buffer, 6% Trehalose |
Residues |
1-211aa |
Sequence |
MAPSRNGMVLKPHFHKDWQRRVATWFNQPARKIRRRKARQAKARRIAPRPASGPIRPIVRCPTVRYHTKVRAGRGFSLEELRVAGIHKKVARTIGISVDPRRRNKSTESLQANVQRLKEYRSKLILFPRKPSAPKKGDSSAEELKLATQLTGPVMPVRNVYKKEKARVITEEEKNFKAFASLRMARANARLFGIRAKRAKEAAEQDVEKKK |
Product Form |
Lyophilized powder |
Tags |
N-terminal His Tag |
Type |
Recombinant Protein |
Applications |
SDS-PAGE; WB; ELISA; Bioactivity Testing; Immunogen |
Storage |
Store at -20°C/-80°C. Avoid freeze-thaw cycles. |
Target
Alternative Names |
Ribosomal Protein L13; D16S444E; Large Ribosomal Subunit Protein EL13; 60S Ribosomal Protein L13 |
Gene ID |
6137 |
UniProt ID |
P26373 |
Location |
Cytoplasm |
Introduction |
RPL13 plays a role in the antiviral immune response triggered by the foot-and-mouth disease virus (FMDV) by inhibiting its replication. Overexpression of RPL13 enhances the induction and activation of promoters. |
For Research Use Only. Not for Diagnostic or Therapeutic Applications.